Authorization

Sanofi Reportedly Considers Acquisitions Of U.S. Biotechnology Companies

(RTTNews) - Sanofi (SNYNF, SNY) is considering potential acquisitions of U.S. biotechnology companies including Principia Biopharma as it seeks treatments for clinical areas including multiple sclerosis and immune disorders, Bloomberg reported citing people familiar with the matter.

Sanofi is working with advisers to study potential deals, the report said.

Sanofi could spend as much as $50 billion on acquisitions after announcing the disposal of its stake in Regeneron Pharmaceuticals Inc., Bloomberg reported in May.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Февраль 2021    »
ПнВтСрЧтПтСбВс
1234567
891011121314
15161718192021
22232425262728